DAIICHI SANKYO PORTUGAL secures contract for 1638/2025 - Invitation To The Presentation Of A Direct Adjustment Proposal For The Acquisition Of T1823 - Trastuzumab Deruxtecan [100 Mg; Disc Solo Inj; Frs]

Portugal, July 23 -- Portugal based DAIICHI SANKYO PORTUGAL has secured contract from Unidade Local De Saude Da Guarda, E. P. E. for 1638/2025 - Invitation To The Presentation Of A Direct Adjustment Proposal For The Acquisition Of T1823 - Trastuzumab Deruxtecan [100 Mg; Disc Solo Inj; Frs]. The value of the contract is worth 3200000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....